Status:

COMPLETED

Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic Dermatitis

Lead Sponsor:

Galderma R&D

Conditions:

Scalp Seborrheic Dermatitis

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The objective is to assess different treatment regimens with Clobetasol propionate shampoo 0.05% in the treatment of scalp Seborrheic Dermatitis.

Detailed Description

The objective is to assess different treatment regimens with Clobetasol propionate shampoo 0.05% in association with an antifungal shampoo (Ketoconazole 2%) in the treatment of moderate to severe scal...

Eligibility Criteria

Inclusion

  • Subjects with moderate to severe scalp Seborrheic Dermatitis

Exclusion

  • Subjects suffering from psoriasis,
  • Subjects with a known allergy to one of the components of the test products,
  • Female subjects who are pregnant, nursing or planning a pregnancy during the study

Key Trial Info

Start Date :

March 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2010

Estimated Enrollment :

326 Patients enrolled

Trial Details

Trial ID

NCT00862654

Start Date

March 1 2009

End Date

February 1 2010

Last Update

February 18 2021

Active Locations (18)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (18 locations)

1

Galderma Investigational Center

Bruges, Belgium

2

Galderma Investigational Center

Brussels, Belgium

3

Galderma Investigational Center

Geel, Belgium

4

Galderma Investigational Center

Ghent, Belgium